RS50126B - Hidrat 5-[4-[2-(n-metil-n-(2-piridil)amino)etoksi]benzil]tiazolidin -2,4-dion, so maleinske kiseline - Google Patents

Hidrat 5-[4-[2-(n-metil-n-(2-piridil)amino)etoksi]benzil]tiazolidin -2,4-dion, so maleinske kiseline

Info

Publication number
RS50126B
RS50126B YUP-363/00A YU36300A RS50126B RS 50126 B RS50126 B RS 50126B YU 36300 A YU36300 A YU 36300A RS 50126 B RS50126 B RS 50126B
Authority
RS
Serbia
Prior art keywords
hydrate
methyl
thiazolidine
pyridyl
ethoxy
Prior art date
Application number
YUP-363/00A
Other languages
English (en)
Serbian (sr)
Inventor
Paul David James Blackler
David C. Lee
Michael John Sasse
Original Assignee
Smithkline Beecham P.L.C.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C., filed Critical Smithkline Beecham P.L.C.,
Publication of YU36300A publication Critical patent/YU36300A/sh
Publication of RS50126B publication Critical patent/RS50126B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
YUP-363/00A 1997-12-16 1998-12-14 Hidrat 5-[4-[2-(n-metil-n-(2-piridil)amino)etoksi]benzil]tiazolidin -2,4-dion, so maleinske kiseline RS50126B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9726566.4A GB9726566D0 (en) 1997-12-16 1997-12-16 Novel pharmaceutical

Publications (2)

Publication Number Publication Date
YU36300A YU36300A (sh) 2004-03-12
RS50126B true RS50126B (sr) 2009-03-25

Family

ID=10823692

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-363/00A RS50126B (sr) 1997-12-16 1998-12-14 Hidrat 5-[4-[2-(n-metil-n-(2-piridil)amino)etoksi]benzil]tiazolidin -2,4-dion, so maleinske kiseline

Country Status (35)

Country Link
EP (2) EP1040110A1 (instruction)
JP (1) JP2002508373A (instruction)
KR (1) KR100549142B1 (instruction)
CN (3) CN101302215A (instruction)
AP (1) AP1365A (instruction)
AR (1) AR017214A1 (instruction)
AU (1) AU1967999A (instruction)
BG (1) BG64988B1 (instruction)
BR (1) BR9813600A (instruction)
CA (1) CA2314107A1 (instruction)
CO (1) CO4980880A1 (instruction)
CZ (1) CZ299965B6 (instruction)
DZ (1) DZ2681A1 (instruction)
EA (1) EA004260B1 (instruction)
EG (1) EG22337A (instruction)
GB (1) GB9726566D0 (instruction)
HR (1) HRP20000408B1 (instruction)
HU (1) HUP0100509A3 (instruction)
IL (1) IL136424A (instruction)
IN (1) IN192487B (instruction)
MA (1) MA26580A1 (instruction)
MY (1) MY135612A (instruction)
NO (1) NO317254B1 (instruction)
OA (1) OA11766A (instruction)
PE (1) PE20000058A1 (instruction)
PL (1) PL341146A1 (instruction)
RS (1) RS50126B (instruction)
SA (1) SA99191115B1 (instruction)
SK (1) SK286618B6 (instruction)
TR (2) TR200001799T2 (instruction)
TW (1) TW509690B (instruction)
UA (1) UA72198C2 (instruction)
UY (2) UY25304A1 (instruction)
WO (1) WO1999031095A1 (instruction)
ZA (1) ZA9811506B (instruction)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
TR200103060T2 (tr) * 1999-04-23 2002-05-21 Smithkline Beecham P. L. C. Yeni farmasötik maddeler
CA2370258A1 (en) 1999-04-23 2000-11-02 Paul David James Blackler Thiazolidinedione derivative and its use as antidiabetic
AU765005B2 (en) * 1999-04-23 2003-09-04 Smithkline Beecham Plc Polymorph of 5-(4-(2- (N-methyl-N-( 2-pyridyl)amino) ethoxy)benzyl) thiazolidine-2,4-dione, maleic acid salt
US6770133B2 (en) 2000-04-25 2004-08-03 Kyorin Pharmaceutical Co., Ltd. Stable crystal of thiazolidinedione derivative and process for producing the same
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
GB0021784D0 (en) * 2000-09-05 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0021978D0 (en) * 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
UA75370C2 (en) * 2000-09-26 2006-04-17 Reddys Lab Ltd Dr Polymorphic forms of 5-[4-[2(n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2.4-dione maleate
IL155036A0 (en) * 2000-09-26 2003-10-31 Reddy Research Foundation Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl) amino] ethoxy] benzyl] thiazolidine-2,4-dione maleate and pharmaceutical compositions containing the same
WO2003050112A1 (en) * 2001-12-13 2003-06-19 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP2184055A1 (en) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Process for preparing solid dosage forms of rosiglitazone maleate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
CN1083715C (zh) * 1994-02-10 2002-05-01 史密丝克莱恩比彻姆有限公司 胰岛素敏化物治疗肾病的应用

Also Published As

Publication number Publication date
AP2000001831A0 (en) 2000-06-30
SK9172000A3 (en) 2001-01-18
TW509690B (en) 2002-11-11
EP1040110A1 (en) 2000-10-04
KR100549142B1 (ko) 2006-02-03
DZ2681A1 (fr) 2004-06-20
IN192487B (instruction) 2004-04-24
NO317254B1 (no) 2004-09-27
TR199802625A2 (xx) 1999-10-21
PE20000058A1 (es) 2000-02-26
BG64988B1 (bg) 2006-11-30
NO20003069D0 (no) 2000-06-15
UA72198C2 (en) 2005-02-15
PL341146A1 (en) 2001-03-26
CN101302215A (zh) 2008-11-12
HUP0100509A2 (hu) 2002-05-29
SK286618B6 (sk) 2009-02-05
OA11766A (en) 2005-07-19
EG22337A (en) 2002-12-31
UY25304A1 (es) 2000-12-29
BR9813600A (pt) 2000-10-10
SA99191115B1 (ar) 2006-10-11
EA004260B1 (ru) 2004-02-26
AR017214A1 (es) 2001-08-22
BG104603A (en) 2001-03-30
CZ20002204A3 (cs) 2000-11-15
KR20010033141A (ko) 2001-04-25
JP2002508373A (ja) 2002-03-19
CO4980880A1 (es) 2000-11-27
CZ299965B6 (cs) 2009-01-07
AU1967999A (en) 1999-07-05
HUP0100509A3 (en) 2002-06-28
MY135612A (en) 2008-05-30
EP1661895A1 (en) 2006-05-31
UY25308A1 (es) 1999-07-19
GB9726566D0 (en) 1998-02-11
WO1999031095A1 (en) 1999-06-24
IL136424A (en) 2003-12-10
EA200000654A1 (ru) 2000-12-25
CN1281453A (zh) 2001-01-24
CA2314107A1 (en) 1999-06-24
TR200001799T2 (tr) 2001-01-22
HRP20000408A2 (en) 2000-08-31
AP1365A (en) 2005-01-26
HRP20000408B1 (hr) 2008-04-30
CN101381367A (zh) 2009-03-11
ZA9811506B (en) 2000-11-06
MA26580A1 (fr) 2004-12-20
NO20003069L (no) 2000-06-15
TR199802625A3 (tr) 1999-10-21
IL136424A0 (en) 2001-06-14
YU36300A (sh) 2004-03-12

Similar Documents

Publication Publication Date Title
ES2203453T3 (es) Polimorfo de sal del acido maleico de 5-(4-(2-(n-metil-n-(2-piridil)amino)etoxi)bentil)tiazolidina-2,4-diona.
RS50126B (sr) Hidrat 5-[4-[2-(n-metil-n-(2-piridil)amino)etoksi]benzil]tiazolidin -2,4-dion, so maleinske kiseline
RS50080B (sr) Hidrat 5-(4-(2-9n-metil-n-(2- piridil)amino)etoksi)benzil)tiazolidin-2,4-dion soli maleinske kiseline
ES2204557T3 (es) Derivado de tiazolidindiona y su uso como antidiabetico.
HRP20000405A2 (en) Hydrate of 5-/4-/2-(n-methyl-n-(2-pyridil)amino) ethoxy)benzyl/thiazolidine-2,4-dione, maleic acid salt
HRP20010774A2 (en) Thiazolidinedione derivative and its use as antidiabetic
BG65864B1 (bg) Фармацевтично средство
BG107679A (bg) Натриеви соли на 5-[4-[2-(n-метил-n-(2-пиридил)амино)етокси]бензил]тиазолидин-2,4-дион
BG107356A (bg) 5-(4-(2-(n-метил-n-(2-пиридил)амино)етокси)бензил)тиазолидин-2,4-дион хидройодид като фармацевтиченсъстав
ZA200108722B (en) Thiazolidinedione derivative and its use as antidiabetic.